GlassScriptPhysician profile
Cassandra Rochon Singleton
NPI 1912001454
$857.86
in general payments reported to CMS, 2019-2025
15 companies · $281 in 2025
The $281 reported for 2025 was more than what 83% of Pediatrics (Nurse Practitioner) providers received nationally (typical 2025 total: $93.49).
See the full distribution for Pediatrics (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $134 · 2022: $197 · 2023: $138 · 2024: $109 · 2025: $281.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $527.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $527.48 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $160.10 | 2021-2025 | Bexsero, Pediarix, Rotarix |
| Merck Sharp & Dohme LLC | $115.88 | 2021-2025 | Gardasil 9, Vaxelis, Vaxneuvance |
| Phadia US INC. | $89.34 | 2022-2025 | Immunocap |
| Cranial Technologies, INC | $77.27 | 2023-2025 | Doc Band |
| Sanofi Pasteur INC. | $68.10 | 2021-2025 | |
| Alexion Pharmaceuticals, INC. | $62.24 | 2021-2022 | |
| Collegium Pharmaceutical, INC. | $60.64 | 2025 | Jornay Pm |
| Sobi, INC | $45.30 | 2021 | |
| Cipher Pharmaceuticals US LLC | $44.44 | 2025 | Natroba, Spinosad |
| Abiomed | $29.70 | 2024 | Impella |
| Acadia Pharmaceuticals INC | $26.77 | 2024 | Daybue |
| Tris Pharma INC | $22.46 | 2025 | Onyda Xr |
| Nestle Healthcare Nutrition INC. | $20.45 | 2023 | |
| Pfizer INC. | $19.84 | 2022 | |
| Seqirus USA INC | $15.33 | 2025 | Flucelvax |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Cassandra Singleton listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.